Efficacy and Safety of BMS-986256 Compared with Placebo in Participants with Active Systemic Lupus Erythematosus

People with Systemic Lupus Erythematosus are asked to participate in a research study being conducted by The Feinstein Institutes for Medical Research.

You may be eligible to participate in this study if you:

• Are at least 18 years of age
• Are using at least 1 background SLE treatment prior to screening
• Test positive, as determined by the central laboratory, for at least 1 of the following lupus-related autoantibodies at the time of screening
• Have moderate arthritis, tendonitis, tenosynovitis or severe arthritis

You may NOT participate in this study if you:

• Have active severe lupus nephritis (LN)
• Have had any major surgery within the last 30 days
• Have concomitant fibromyalgia
• Have acute coronary syndrome
• Have current or recent gastrointestinal disease
• Have any current or history of cancer or lymphoproliferative disease
• Are pregnant or breastfeeding

Contact Information
Andrew Shaw, Study Coordinator
Phone: 516-562-2591